section name header

Pronunciation ⬇

trye-FAR-oh-teen

Classifications ⬆ ⬇

Therapeutic Classification: antiacne agents

Pharmacologic Classification: retinoids

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Stimulates retinoic acid receptors, resulting in anti-inflammatory effects.
Therapeutic effects:
  • Decreased severity of acne vulgaris.

Pharmacokinetics ⬆ ⬇

Absorption: Minimal systemic absorption.

Distribution: Unknown.

Protein Binding: >99%.

Metabolism/Excretion: Primarily metabolized by CYP2C8, CYP2C9, and CYP3A4. Primarily excreted in feces.

Half-Life: 2–9 hr.

Time/Action Profile ⬆ ⬇

(improvement in lesions)

ROUTEONSETPEAKDURATION
Topicalwithin 12 wksUnknownUnknown



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Local: burning/stinging, erythema, itching, photosensitivity, scaling

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Aklief